MACROPHAGE ACTIVATING FACTOR FOR USE IN THE TREATMENT OF CHRONIC FATIGUE SYNDROME (CFS) AND CFS-RELATED DISEASES AND DISORDERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13472688

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to Macrophage Activating Factors such as GcMAF and compositions thereof, for use in the treatment of a patient suffering from CFS/ME and/or XMRV infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROTEA BIOPHARMA N VDE TYRASLAAN 111 NEDER-OVER-HEEMBEEK B-1120

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De, Meirleir Kenny Mechelen, BE 7 4
Roelant, Christiaan Leuven, BE 5 20

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation